GESTATIONAL TROPHOBLASTIC DISEASES: FOURTEEN YEAR EXPERIENCE OF OUR CLINIC

被引:4
|
作者
Kurdoglu, Mertihan [1 ]
Kurdoglu, Zehra [1 ]
Kucukaydin, Zehra [1 ]
Sahin, Hanim Guler [1 ]
Kamaci, Mansur [1 ]
机构
[1] Yuzuncu Yil Univ, Fac Med, Dept Gynecol & Obstet, Van, Turkey
关键词
gestational trophoblastic disease; hydatidiform mole; incidence;
D O I
10.5505/tjod.2011.98470
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the patients followed and treated with a diagnosis of gestational trophoblastic disease in our clinic retrospectively. Design: The files of the patients followed and treated in our clinic between 1996 and 2010 with a diagnosis of gestational trophoblastic disease were examined. Setting: Yuzuncu YIl University, Faculty of Medicine, Department of Obstetrics and Gynecology, Van. Patients: The 147 patients with satisfactory information in their files within 173 patients treated and followed in our clinic between 1996 and 2010 with a diagnosis of gestational trophoblastic disease. Interventions: No intervention to the patients. Main outcome measures: Demographic and obstetric parameters, blood group, obstetric history in the previous pregnancy, contraceptive method, gestational week and complaints on admission, hystological type, stage, treatment and complications of gestational trophoblastic disease and presence of associated clinical problems. Results: In our clinic, 18.324 deliveries occured and 173 cases had a diagnosis of gestational trophoblastic disease between 1996 and 2010. Out of 147 patients, 72 (49%), 61 (41.5%), 3 (2%), 7 (4.8%) and 1 (0.7%) had diagnoses of complete mole, partial mole, invasive mole, choriocarcinoma and placental site trophoblastic tumor, respectively. In 3 patients ( 2%), subtype could not be determined. Mean age was 31.45 +/- 10.29 years and the most common complaint was vaginal bleeding (77.6%). As the primary therapy, suction curettage with oxytocin infusion or hysterectomy was appplied to 140 and 7 patients, respectively. A single agent chemotherapy was performed to 26 patients while a multiagent chemotherapy was given to 6 patients. All patients were followed up by serial serum beta-hCG measurements. Conclusions: The incidence of gestational trophoblastic disease in our clinic was calculated as 8.1 per 1000 deliveries and socio-economic and educational status of majority of the patients were low. Lowering the high birth rate in our region may contribute to decrease of disease incidence.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 50 条
  • [31] Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases
    Buza, Natalia
    Hui, Pei
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2014, 31 (03) : 223 - 232
  • [32] Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases
    Cole, Laurence A.
    Muller, Carolyn Y.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (01) : 3 - 9
  • [33] Expression of epidermal growth factor receptor in gestational trophoblastic diseases
    Balaram, P
    John, M
    Rajalekshmy, TN
    Nair, B
    Schultz, G
    Nair, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (03) : 161 - 166
  • [34] Lectin binding as a prognostic indicator in gestational trophoblastic diseases (GTD)
    Balaram, P
    Kutty, JM
    Rajalekshmi, TN
    Remani, P
    Swapna, E
    Nair, MK
    Nair, B
    IN VIVO, 1996, 10 (06): : 607 - 611
  • [35] Expression of epidermal growth factor receptor in gestational trophoblastic diseases
    Balaram P.
    John M.
    Rajalekshmy T.N.
    Nair B.
    Schultz G.
    Nair K.
    Journal of Cancer Research and Clinical Oncology, 1997, 123 (3) : 161 - 166
  • [36] The Role of Surgery in the Management of Gestational Trophoblastic Neoplasia The Hungarian Experience
    Fueloep, Vilmos
    Szigetvari, Ivan
    Szepesi, Janos
    Vegh, Gyorgy
    Zsirai, Laszlo
    Berkowitz, Ross S.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2016, 61 (5-6) : 197 - 204
  • [37] Gestational trophoblastic disease in the western region of Saudi Arabia (single-institute experience)
    Anfinan, Nisrin
    Sait, Khalid
    Sait, Hesham
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 180 : 8 - 11
  • [38] Thyroid function among women with gestational trophoblastic diseases. A cross-sectional study
    Dugerogul, Harun
    Ozgenoglu, Murat
    SAO PAULO MEDICAL JOURNAL, 2019, 137 (03): : 278 - 283
  • [39] A new death domain associated with gestational trophoblastic diseases induces apoptosis in distinct cell types
    Dumur, CI
    Almenara, JA
    Durand, S
    Flury, A
    Koritschoner, NP
    Patrito, LC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (06) : 1161 - 1167
  • [40] Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases
    John, M
    Rajalekshmy, TN
    Nair, B
    Augustine, J
    Schultz, G
    Nair, K
    Balaram, P
    ONCOLOGY REPORTS, 1997, 4 (01) : 177 - 182